Surface Oncology, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Surface Oncology, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2022.
  • Surface Oncology, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $77K, a 99.6% decline year-over-year.
  • Surface Oncology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $31.7M, a 25.5% decline from 2021.
  • Surface Oncology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $42.5M, a 6.03% increase from 2020.
  • Surface Oncology, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $40.1M, a 441% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $31.7M -$10.8M -25.5% Jan 1, 2022 Dec 31, 2022 8-K 2023-07-03
2021 $42.5M +$2.42M +6.03% Jan 1, 2021 Dec 31, 2021 8-K 2023-07-03
2020 $40.1M +$32.7M +441% Jan 1, 2020 Dec 31, 2020 8-K 2023-07-03
2019 $7.42M -$103M -93.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
2018 $110M +$111M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-09
2017 -$1.04M -$27M -104% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
2016 $25.9M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.